Bio Rad Laboratories Inc (NYSE:BIO)
| 372.43 BATS BZX Real-Time Price As of 11:29am ET |  +1.07 / +0.29%Today’s Change | 344.63 Today|||52-Week Range 572.70 | -11.43% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Operating Activities | Net Income / Starting Line | 269.3M | -828.5M | 865.2M | 598.8M | |
| Depreciation | 34.9M | 34.5M | 42.9M | 43.0M | ||
| Total Other Cash Flow | -314.2M | 1.1B | -1.1B | -715.5M | ||
| Funds From Operations | 60.5M | 124.7M | 85.6M | 83.6M | ||
| Funds From/For Other Operating Expenses | -1.8M | 19.7M | 42.7M | -71.8M | ||
| Net Cash Flow - Operating Activities | 62.3M | 105.0M | 42.9M | 155.4M | ||
| Investing | Increase In Investments | -103.8M | -83.9M | -95.4M | -76.2M | |
| Decrease In Investments | 96.2M | 82.9M | 104.9M | 83.4M | ||
| Capital Expenditures | -22.1M | -53.9M | -23.6M | -22.2M | ||
| Fixed Asset Disposal | 218.0K | 42.0K | 74.0K | 12.0K | ||
| Net Assets From Acquisitions | 0.00 | 0.00 | -16.1M | 0.00 | ||
| Other Investing - Sources | 0.00 | 0.00 | 7.4M | -20.0K | ||
| Net Cash Flow Investing | -29.5M | -54.8M | -22.7M | -15.1M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | -90.0K | -1.4M | -237.0K | -122.0K | ||
| Net Proceeds Stock Sale | -1.3M | 12.1M | 3.8M | 3.9M | ||
| Common Preferred Redeemed | 0.00 | -48.9M | 0.00 | -15.0M | ||
| Common Dividends | -- | -- | -- | -- | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 808.0K | 8.9M | 1.4M | 4.4M | ||
| Net Cash Flow - Financing | -2.2M | -47.0M | 2.2M | -15.6M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | 912.0K | -4.6M | 2.0M | 145.0K | |
| Net Change In Cash | 30.6M | 3.2M | 22.4M | 124.7M | ||
